Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Driving Timely Biomarker Testing to Optimize Treatment Decisions for Colorectal Cancer Patients

Pfizer Inc

While rapid progress is being made towards achieving timely access to biomarker testing for
mCRC across Canada, a recent expanded quality assurance program has identified important
disparities in pre-analytical and post-analytical processes in mCRC biomarker testing,leading to substantial differences in turnaround time, analyticaccuracy and reporting quality amongst Canadian centres. These observations suggest the need for continued quality improvement in mCRC biomarker testing addressing both analytical and non-analytical parameters

Pfizer supports the global healthcare community’s independent initiatives, e.g.,
research, quality improvement or education, to improve patient outcomes in areas of
unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Colorectal Cancer Canada (CCC) is Canada’s patient led not-for-profit patient
association dedicated to colorectal cancer awareness and education, support for
patients and their caregivers, and advocacy on their behalf and aspires to reduce the
incidence and mortality of colorectal cancer in Canada while improving the quality of
life of patients, their families and their caregivers. Founded in 1998, CCC has been an
advocate for Canadian CRC patients for over twenty-five years. Through the Get
Personal project and numerous other educational and research initiatives, CCC has
prioritized the improvement of timely access to biomarker testing for Canadian mCRC
patients among its many important objectives.

Specialties

Others

Eligibility Requirements

Applicants are strongly encouraged to use a multidisciplinary care model (e.g., pathologist, medical oncologist, surgeon, researcher. etc.). All partners must have a relevant role, and the requesting organization as defined below must have a key role in the project.
• Only organizations are eligible to receive grants, not individuals or medical practice groups.
• The following may apply: medical schools; healthcare institutions (both large and small);
professional associations; government agencies; and other entities with a mission related
to healthcare improvement.
• Projects should start in 2026 with duration of up to a maximum of 24 months.

Eligible Countries:

Canada

Sponsor Details

Sponsor Institute/Organizations: Pfizer Inc

Sponsor Type: Corporate/Non-Profit

Address: 66 Hudson Boulevard East New York, NY

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity